PubRank

H B El-Serag

Author PubWeight™ 56.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005 7.35
2 Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005 2.90
3 The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 2007 2.59
4 The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther 2005 2.40
5 The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007 2.10
6 Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009 1.83
7 The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 2006 1.65
8 Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol 2001 1.56
9 The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther 2013 1.45
10 Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther 2012 1.45
11 Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther 2012 1.40
12 Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther 2007 1.39
13 The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol 2001 1.32
14 The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther 2014 1.14
15 Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther 2008 1.12
16 Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther 2007 1.08
17 Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther 2010 1.07
18 Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther 2008 1.06
19 Patients' intuitive judgments about surveillance endoscopy in Barrett's esophagus: a review and application to models of decision-making. Dis Esophagus 2013 1.03
20 Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer 2013 1.02
21 Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 2000 0.99
22 Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther 2003 0.96
23 Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther 2010 0.93
24 Views of hepatitis C virus patients delayed from treatment for psychiatric reasons. J Viral Hepat 2007 0.92
25 Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci 1998 0.92
26 Diagnostic yield of oesophagogastroduodenoscopy in children with abdominal pain. Aliment Pharmacol Ther 2009 0.90
27 Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data. Aliment Pharmacol Ther 2014 0.90
28 Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system. Aliment Pharmacol Ther 2004 0.89
29 Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus 2009 0.87
30 Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. Minerva Gastroenterol Dietol 2009 0.87
31 Celiac sprue among US military veterans: associated disorders and clinical manifestations. Dig Dis Sci 1999 0.85
32 Irritable bowel syndrome symptoms and health related quality of life in female veterans. Aliment Pharmacol Ther 2009 0.83
33 Metabolic syndrome and the risk of Barrett's oesophagus in white males. Aliment Pharmacol Ther 2015 0.82
34 The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther 2013 0.82
35 Poor sleep quality and obstructive sleep apnea in patients with GERD and Barrett's esophagus. Neurogastroenterol Motil 2013 0.81
36 Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study. Aliment Pharmacol Ther 2005 0.78
37 Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large Veterans Administration Medical Centre. Aliment Pharmacol Ther 2008 0.78
38 Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus. Aliment Pharmacol Ther 2013 0.78
39 Increased use of low anterior resection for veterans with rectal cancer. Aliment Pharmacol Ther 2005 0.78
40 GI Epidemiology: databases for epidemiological studies. Aliment Pharmacol Ther 2007 0.77
41 Esophageal eosinophilia after radiofrequency ablation for Barrett's esophagus. Dis Esophagus 2013 0.76
42 Segment length and risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 2000 0.75
43 Economic aspects of endoscopic screening for intestinal precancerous conditions. Gastrointest Endosc Clin N Am 1997 0.75
44 Barrett's esophagus, hiatal hernia, and logistic regression analysis. Am J Gastroenterol 1999 0.75
45 Personal and family history of cancer and the risk of Barrett's esophagus in men. Dis Esophagus 2014 0.75
46 Hepatocellular carcinoma at the cutting edge of science and practice. Minerva Med 2010 0.75
47 Interferon: benefit beyond hepatitis therapy? Am J Gastroenterol 2001 0.75
48 Hepatology 2014: where are we going? Minerva Gastroenterol Dietol 2014 0.75